Helix BioPharma Corp.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Helix BioPharma Corp.'s yearly results, compared with Healthcare companies in Canada. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
Helix BioPharma Corp. made a loss over the last year. Helix BioPharma Corp. owes C$0.31 for every C$1 it owns.
Compared with Healthcare companies in Canada · latest annual results Jul 2025.
P/E ratio
LossHelix BioPharma Corp. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
5.15The share price is 5.15 times Helix BioPharma Corp.'s book value per share, higher than 75% of Healthcare companies in Canada.
Market cap
C$76 MThe total market value of all of Helix BioPharma Corp.'s shares at today's price (share price × number of shares), larger than 67% of Healthcare companies in Canada. PosiCap size class: Micro Cap.
Net worth (book value)
C$15 MWhat Helix BioPharma Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Apr 2026).
Book value per share
C$0.19Net worth divided by the number of shares. The share price of C$0.99 is 5.1 times this, which is the P/B above.
Return on equity (ROE)
-50.0%Helix BioPharma Corp. lost 50.0% of its shareholders' money over the last year, lower than 65% of Healthcare companies in Canada.
Owes vs Owns
0.31×Helix BioPharma Corp. owes C$0.31 for every C$1 it owns (low), lower than 73% of Healthcare companies in Canada.
Dividend yield
NoneHelix BioPharma Corp. does not currently pay a dividend.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Helix BioPharma Corp.: C$76 M ÷ C$15 M (30 Apr 2026) = 5.1.
What is Helix BioPharma Corp.'s return on equity?
Helix BioPharma Corp. lost 50.0% of its shareholders' money over the last year, lower than 65% of Healthcare companies in Canada.
How much does Helix BioPharma Corp. owe compared with what it owns?
Helix BioPharma Corp. owes C$0.31 for every C$1 it owns (low), lower than 73% of Healthcare companies in Canada.
Does Helix BioPharma Corp. pay a dividend?
No. Helix BioPharma Corp. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.